Skip to Content

Elanco Animal Health Inc ELAN

Morningstar Rating
$14.22 +0.09 (0.64%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ELAN is trading at a 762% premium.
Price
$14.13
Fair Value
$53.89
Uncertainty
Very High
1-Star Price
$49.58
5-Star Price
$46.13
Economic Moat
Qnmh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ELAN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$14.13
Day Range
$13.8314.28
52-Week Range
$8.5218.80
Bid/Ask
$13.69 / $14.49
Market Cap
$7.03 Bil
Volume/Avg
4.1 Mil / 5.1 Mil

Key Statistics

Price/Earnings (Normalized)
18.24
Price/Sales
1.61
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
9,800

Comparables

Valuation

Metric
ELAN
ZTS
OFSA3
Price/Earnings (Normalized)
18.2432.4619.84
Price/Book Value
1.1615.811.44
Price/Sales
1.619.231.05
Price/Cash Flow
15.3828.0213.17
Price/Earnings
ELAN
ZTS
OFSA3

Financial Strength

Metric
ELAN
ZTS
OFSA3
Quick Ratio
1.161.712.51
Current Ratio
3.293.333.48
Interest Coverage
−3.6313.063.26
Quick Ratio
ELAN
ZTS
OFSA3

Profitability

Metric
ELAN
ZTS
OFSA3
Return on Assets (Normalized)
2.60%17.68%3.91%
Return on Equity (Normalized)
5.79%51.21%7.38%
Return on Invested Capital (Normalized)
4.82%22.36%6.69%
Return on Assets
ELAN
ZTS
OFSA3
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
JdcgggpcfMrsr$79.8 Bil
Merck KGaA ADR
MKKGY
NkmlrryhbhNdpyjnv$71.7 Bil
Haleon PLC ADR
HLN
QkhpysqpXbq$37.5 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
LkpvvccKykz$13.0 Bil
Viatris Inc
VTRS
LdqjbdfnjSyv$12.3 Bil
Catalent Inc
CTLT
WjvwjzfkpKbctwl$10.3 Bil
Perrigo Co PLC
PRGO
ClbyhckvGkzxj$3.5 Bil
Prestige Consumer Healthcare Inc
PBH
ZdygllwgdXdtzrfx$3.4 Bil
Curaleaf Holdings Inc
CURLF
JtmgzxbxFrvd$2.8 Bil
Green Thumb Industries Inc
GTBIF
HlxtslcsmwBxd$2.7 Bil

Sponsor Center